91 related articles for article (PubMed ID: 20428205)
1. Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib.
Biagi C; Astolfi A; Masetti R; Serravalle S; Franzoni M; Chiarini F; Melchionda F; Pession A
Leukemia; 2010 Jun; 24(6):1230-3. PubMed ID: 20428205
[No Abstract] [Full Text] [Related]
2. Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma.
Alonso-Alonso R; Mondéjar R; Martínez N; García-Diaz N; Pérez C; Merino D; Rodríguez M; Esteve-Codina A; Fuste B; Gut M; Burrows F; Scholz C; Vaqué JP; Gualberto A; Piris MÁ
Sci Rep; 2020 Apr; 10(1):6721. PubMed ID: 32317694
[TBL] [Abstract][Full Text] [Related]
3. In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets.
Goemans BF; Zwaan CM; Harlow A; Loonen AH; Gibson BE; Hählen K; Reinhardt D; Creutzig U; Heinrich MC; Kaspers GJ
Blood; 2005 Nov; 106(10):3532-7. PubMed ID: 16051737
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of the absence of biallelic deletion at the
Farah N; Kirkwood AA; Rahman S; Leon T; Jenkinson S; Gale RE; Patrick K; Hancock J; Samarasinghe S; Linch DC; Moorman AV; Goulden N; Vora A; Mansour MR
Haematologica; 2018 Jul; 103(7):e288-e292. PubMed ID: 29519867
[No Abstract] [Full Text] [Related]
5. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
6. Sustained remission in a patient with PDGFR-beta-rearranged T-lymphoblastic lymphoma and complete remission with dasatinib.
Shah KP; Carroll CM; Mosse C; Yenamandra A; Borinstein SC
Pediatr Blood Cancer; 2020 Jan; 67(1):e28026. PubMed ID: 31571404
[No Abstract] [Full Text] [Related]
7. Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.
Crombet O; Lastrapes K; Zieske A; Morales-Arias J
Pediatr Blood Cancer; 2012 Aug; 59(2):333-4. PubMed ID: 22689211
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing reveals the subclonal expression of NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
Tsurusaki Y; Nagai JI; Fujita S; Sugiyama M; Nakamura W; Hayashi A; Miyagawa N; Keino D; Yokosuka T; Iwasaki F; Hamanoue S; Shiomi M; Goto S; Kurosawa K; Goto H
Pediatr Blood Cancer; 2020 Jan; 67(1):e28019. PubMed ID: 31556219
[No Abstract] [Full Text] [Related]
9. Activation of PP2A by perphenazine induces apoptosis in T-ALL.
Cancer Discov; 2014 Mar; 4(3):OF14. PubMed ID: 24596208
[TBL] [Abstract][Full Text] [Related]
10. Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia.
Goossens S; Van Vlierberghe P
PLoS Med; 2016 Dec; 13(12):e1002208. PubMed ID: 27997538
[TBL] [Abstract][Full Text] [Related]
11. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
[TBL] [Abstract][Full Text] [Related]
12. Precursor T-cell acute lymphoblastic lymphoma presenting as a tongue mass.
Friedman AD; Cook JR; Scharpf J
J Otolaryngol Head Neck Surg; 2009 Feb; 38(1):E16-8. PubMed ID: 19344598
[No Abstract] [Full Text] [Related]
13. Drugging DNA repair to target T-ALL cells.
Dasgupta Y; Golovine K; Nieborowska-Skorska M; Luo L; Matlawska-Wasowska K; Mullighan CG; Skorski T
Leuk Lymphoma; 2018 Jul; 59(7):1746-1749. PubMed ID: 29115896
[No Abstract] [Full Text] [Related]
14. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
Meijerink JP; den Boer ML; Pieters R
Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
[TBL] [Abstract][Full Text] [Related]
15. [Acute lymphoblastic leukemia with T + PH1 monocytosis: a case report].
Braham Jmili N; Sendi H; Khelif A
Ann Biol Clin (Paris); 2011; 69(4):473-5. PubMed ID: 21896415
[TBL] [Abstract][Full Text] [Related]
16. Nodular lesions of the scalp and a mediastinal mass in T cell acute lymphoblastic leukemia.
Konik A; Dührsen U; Röth A
Int J Hematol; 2010 Jul; 92(1):3-4. PubMed ID: 20559760
[No Abstract] [Full Text] [Related]
17. NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.
Clarke S; O'Reilly J; Romeo G; Cooney J
Leuk Res; 2011 Jul; 35(7):e131-3. PubMed ID: 21489623
[No Abstract] [Full Text] [Related]
18. Microarray detection of multiple recurring submicroscopic chromosomal aberrations in pediatric T-cell acute lymphoblastic leukemia.
Yu L; Slovak ML; Mannoor K; Chen C; Hunger SP; Carroll AJ; Schultz RA; Shaffer LG; Ballif BC; Ning Y
Leukemia; 2011 Jun; 25(6):1042-6. PubMed ID: 21383747
[No Abstract] [Full Text] [Related]
19. Early T-cell precursor acute lymphoblastic leukaemia.
Taub JW
Lancet Oncol; 2009 Feb; 10(2):105-6. PubMed ID: 19185830
[No Abstract] [Full Text] [Related]
20. RUNX1 point mutations potentially identify a subset of early immature T-cell acute lymphoblastic leukaemia that may originate from differentiated T-cells.
Mok MM; Du L; Wang CQ; Tergaonkar V; Liu TC; Yin Kham SK; Sanda T; Yeoh AE; Osato M
Gene; 2014 Jul; 545(1):111-6. PubMed ID: 24792891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
